FDA Approved EVAR AAA Graft Systems

DEVICE3 trials

Sponsors

Endologix

Conditions

AAAAAA - Abdominal Aortic AneurysmAbdominal Aortic Aneurysm

Unknown Phase

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

CompletedNCT02407457

EndologixAbdominal Aortic Aneurysm

Start: 2015-03-31End: 2022-10-31Updated: 2024-10-01

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

RecruitingNCT05064540

EndologixAAA, AAA - Abdominal Aortic Aneurysm

Start: 2021-09-20End: 2032-03-01Target: 450Updated: 2026-09-09

JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization

WithdrawnNCT05409118

EndologixAAA, AAA - Abdominal Aortic Aneurysm

Start: 2025-12-31End: 2030-12-31Updated: 2025-08-07